Orgenesis Inc. (NasdaqCM:ORGS) agreed to acquire 25% stake in Octomera LLC from MM OS Holdings, L.P. on January 31, 2024. In exchange, MM OS Holdings shall receive a royalty of 5% of the net revenue of Octomera?s cell processing services, for the three calendar years 2025-2027
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.48 USD | -1.03% | -13.07% | -4.13% |
May. 20 | Orgenesis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-4.13% | 16.36M | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.66B | |
+4.91% | 41.3B | |
+21.98% | 31.6B | |
+14.45% | 25.03B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. agreed to acquire 25% stake in Octomera LLC from MM OS Holdings, L.P.